Ziyi Wang
Perth, WA, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 49 publications
PePNet: Pose-Enhanced Point Cloud Network for LiDAR-based Human Action Recognition in Outdoor Long-Range Scenarios.
Journal: IEEE transactions on image processing : a publication of the IEEE Signal Processing Society
Published: July 27, 2026
Higher Promoter Methylation of the Ubiquitin-Associated and SH3 Domain Containing A (UBASH3A) Gene Is Associated With T-Lymphocyte Ontogeny and Reduced Susceptibility to Early-Onset Sepsis.
Journal: The Journal of infectious diseases
Published: June 05, 2025
Accounting for shear scission in the size-exclusion chromatography of debranched starch.
Journal: Analytical and bioanalytical chemistry
Published: February 23, 2025
Corrigendum to "Arctiin abrogates osteoclastogenesis and bone resorption via suppressing RANKL-induced ROS and NFATc1 activation" [Pharmacol. Res. 159 (2020) 104944].
Journal: Pharmacological research
Published: October 24, 2024
Advancing Superconductivity with Interface Engineering.
Journal: Advanced materials (Deerfield Beach, Fla.)
Published: April 08, 2024
Buqi-Tongluo Decoction inhibits osteoclastogenesis and alleviates bone loss in ovariectomized rats by attenuating NFATc1, MAPK, NF-κB signaling.
Journal: Chinese journal of natural medicines
Published: March 08, 2024
Tiliroside is a new potential therapeutic drug for osteoporosis in mice.
Journal: Journal of cellular physiology
Published: February 06, 2024
Liver glycogen fragility in the presence of hydrogen-bond breakers.
Journal: International journal of biological macromolecules
Published: October 27, 2023
Corrigendum: Inhibitory effects of Rhaponticin on osteoclast formation and resorption by targeting RANKL-induced NFATc1 and ROS activity.
Journal: Frontiers in pharmacology
Published: September 20, 2023
AKT/GSK3β/NFATc1 and ROS signal axes are involved in AZD1390-mediated inhibitory effects on osteoclast and OVX-induced osteoporosis.
Journal: International immunopharmacology
Published: April 18, 2022
The Extraction of Liver Glycogen Molecules for Glycogen Structure Determination.
Journal: Journal of visualized experiments : JoVE
Published: February 28, 2022
Cycloastragenol Attenuates Osteoclastogenesis and Bone Loss by Targeting RANKL-Induced Nrf2/Keap1/ARE, NF-κB, Calcium, and NFATc1 Pathways.
Journal: Frontiers in pharmacology
Published: November 06, 2021
Last Updated: 09/26/2026